IRA reforms, including a small molecule fix, could be on the table. Will Trump and the GOP make the leap?

The Inflation Reduction Act seems to be sticking around under the new Trump administration, but the possibility of reform is still on the table. One of those potential targets? Part of the Medicare drug price negotiation program that puts small molecules at a disadvantage.